These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19744015)

  • 1. Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole.
    Rainka MM; Capote HA; Ross CA; Gengo FM
    J Clin Pharm Ther; 2009 Oct; 34(5):595-8. PubMed ID: 19744015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole treatment of risperidone-induced hyperprolactinemia.
    Chen JX; Su YA; Wang SL; Bian QT; Liu YH; Wang N; Yang FD; Haile C; Kosten TR; Zhang XY
    J Clin Psychiatry; 2009 Jul; 70(7):1058-9. PubMed ID: 19653986
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of symptomatic hyperprolactinemia by aripiprazole.
    Wahl R; Ostroff R
    Am J Psychiatry; 2005 Aug; 162(8):1542-3. PubMed ID: 16055781
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.
    Lin SK; Chen CK
    J Clin Psychiatry; 2006 Aug; 67(8):1307. PubMed ID: 16965214
    [No Abstract]   [Full Text] [Related]  

  • 6. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.
    Yasui-Furukori N; Furukori H; Sugawara N; Fujii A; Kaneko S
    J Clin Psychopharmacol; 2010 Oct; 30(5):596-9. PubMed ID: 20814333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK; Huang YS; Ree SC; Hsiao CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary report: a naturalistic study of the effect of aripiprazole addition on risperidone-related hyperprolactinemia in patients treated with risperidone long-acting injection.
    van Kooten M; Arends J; Cohen D
    J Clin Psychopharmacol; 2011 Feb; 31(1):126-8. PubMed ID: 21192158
    [No Abstract]   [Full Text] [Related]  

  • 10. Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.
    Lee BH; Kim YK; Park SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):714-7. PubMed ID: 16571367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole.
    De Berardis D; Fornaro M; Serroni N; Marini S; Piersanti M; Cavuto M; Valchera A; Mazza M; Girinelli G; Iasevoli F; Perna G; Martinotti G; Di Giannantonio M
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):30-7. PubMed ID: 24372345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive treatment with low-dosage aripiprazole for blonanserin-induced hyperprolactinemia in a female patient with schizophrenia.
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1361-2. PubMed ID: 20647025
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for the partial dopamine-receptor agonist aripiprazole as a first-line treatment of psychosis in patients with iatrogenic or tumorogenic hyperprolactinemia.
    Hoffer ZS; Roth RL; Mathews M
    Psychosomatics; 2009; 50(4):317-24. PubMed ID: 19687170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulomatous cutaneous lesions associated with risperidone-induced hyperprolactinemia in an amputated upper limb.
    Lin CH; Ma H; Chung MT; Chou J
    Int J Dermatol; 2012 Jan; 51(1):75-8. PubMed ID: 21834946
    [No Abstract]   [Full Text] [Related]  

  • 15. Aripiprazole reverses paliperidone-induced hyperprolactinemia.
    Basterreche N; Zumárraga M; Arrue A; Olivas O; Dávila W
    Actas Esp Psiquiatr; 2012; 40(5):290-2. PubMed ID: 23076612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole resolves symptomatic hyperprolactinemia in a male schizophrenic patient.
    Chen CH; Huang MC; Lu ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):893-4. PubMed ID: 18082301
    [No Abstract]   [Full Text] [Related]  

  • 17. Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole.
    Paulzen M; Gründer G
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):149-51. PubMed ID: 16942633
    [No Abstract]   [Full Text] [Related]  

  • 18. Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.
    Saitis M; Papazisis G; Katsigiannopoulos K; Kouvelas D
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):624. PubMed ID: 18950388
    [No Abstract]   [Full Text] [Related]  

  • 19. Resolution of haloperidol-induced hyperprolactinemia with aripiprazole.
    Lorenz RA; Weinstein B
    J Clin Psychopharmacol; 2007 Oct; 27(5):524-5. PubMed ID: 17873694
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment with aripiprazole for hyperprolactinemia induced by pituitary microadenoma in a bipolar I disorder patient.
    Chen ST; Hsiao YL
    J Clin Psychopharmacol; 2010 Feb; 30(1):78-80. PubMed ID: 20075655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.